Haemophilus influenzae type b vaccines: lessons for the future.
Ward
J I
JI
Harbor-UCLA Medical Center, UCLA School of Medicine.
Broome
C V
CV
Harrison
L H
LH
Shinefield
H
H
Black
S
S
D016667:Bacterial Capsules; D001428:Bacterial Vaccines / Q000009:adverse effects; D002675:Child, Preschool; D004168:Diphtheria Toxoid; D004812:Epidemiologic Methods; D006192:Haemophilus Infections / Q000209:etiology / Q000517:prevention & control*; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae; D006801:Humans; D007223:Infant; D011135:Polysaccharides, Bacterial; D011358:Product Surveillance, Postmarketing / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration
D001428:Bacterial Vaccines; D004168:Diphtheria Toxoid; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; C052180:Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate; D011135:Polysaccharides, Bacterial